Drug Shortage Report for TRIFLUOPERAZINE
Report ID | 119618 |
Drug Identification Number | 00312754 |
Brand name | TRIFLUOPERAZINE |
Common or Proper name | Trifluoperazine |
Company Name | AA PHARMA INC |
Market Status | DORMANT |
Active Ingredient(s) | TRIFLUOPERAZINE |
Strength(s) | 2MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100BTL |
ATC code | N05AB |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-07-07 |
Estimated end date | 2022-10-15 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-01-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-07-07 | English | Compare |
v2 | 2020-07-07 | French | Compare |
v3 | 2020-07-07 | English | Compare |
v4 | 2020-07-07 | French | Compare |
v5 | 2020-07-08 | English | Compare |
v6 | 2020-07-23 | English | Compare |
v7 | 2020-07-23 | French | Compare |
v8 | 2021-06-17 | English | Compare |
v9 | 2021-06-17 | French | Compare |
v10 | 2022-01-21 | English | Compare |
v11 | 2022-01-21 | French | Compare |
v12 | 2022-01-26 | English | Compare |
v13 | 2022-01-26 | French | Compare |
Showing 1 to 13 of 13